β 3 ‐Adrenoceptor as a potential immuno‐suppressor agent in melanoma

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway

(2018) Yan Cheng et al.   ONCOGENE

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

(2018) Hussein A. Tawbi et al.   NEW ENGLAND JOURNAL OF MEDICINE

β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors

(2018) Massimo Dal Monte et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neutrophils in Homeostasis, Immunity, and Cancer

(2017) José Ángel Nicolás-Ávila et al.   IMMUNITY

β-Blocker use and reduced disease progression in patients with thick melanoma

(2017) Vincenzo De Giorgi et al.   MELANOMA RESEARCH

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

(2017) Simon D Harding et al.   NUCLEIC ACIDS RESEARCH

Immune system and melanoma biology: a balance between immunosurveillance and immune escape

(2017) Anna Passarelli et al.   Oncotarget

β-Adrenergic Signaling Impairs Antitumor CD8 + T-cell Responses to B-cell Lymphoma Immunotherapy

(2017) Michael D. Nissen et al.   Cancer Immunology Research

Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice

(2017) Kathleen M. Kokolus et al.   OncoImmunology

Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8+ T-cell effector function

(2016) Leonardo D. Estrada et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Plasticity beyond Cancer Cells and the “Immunosuppressive Switch”

(2015) Zvi Granot et al.   CANCER RESEARCH

β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis

(2015) W. Kurtis Childers et al.   Clinical Breast Cancer

Inhibition of Human Melanoma Growth by a Non-Cardioselective β-Blocker

(2015) Ludovic J. Wrobel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors

(2015) Federica Sereni et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

(2015) Dass S. Vinay et al.   SEMINARS IN CANCER BIOLOGY

Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression

(2015) Maura Calvani et al.   Oncotarget

Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study

(2014) C. McCourt et al.   BRITISH JOURNAL OF DERMATOLOGY

β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling

(2014) Massimo Dal Monte et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Tumor-Associated Macrophages as a Paradigm of Macrophage Plasticity, Diversity, and Polarization

(2013) Alberto Mantovani et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

β-Blocker use and all-cause mortality of melanoma patients: Results from a population-based Dutch cohort study

(2013) E. Livingstone et al.   EUROPEAN JOURNAL OF CANCER

Beta2-adrenergic receptor signaling in CD4+Foxp3+regulatory T cells enhances their suppressive function in a PKA-dependent manner

(2013) Marcia G. Guereschi et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization

(2013) Massimo Dal Monte et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines

(2013) Silvia Moretti et al.   LABORATORY INVESTIGATION

Autonomic Nerve Development Contributes to Prostate Cancer Progression

(2013) C. Magnon et al.   SCIENCE

Src activation by β-adrenoreceptors is a key switch for tumour metastasis

(2013) Guillermo N. Armaiz-Pena et al.   Nature Communications

Acute Stress Differently Modulates Beta 1, Beta 2 and Beta 3 Adrenoceptors in T Cells, but Not in B Cells, from the Rat Spleen

(2012) Marcela Laukova et al.   NEUROIMMUNOMODULATION

Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth

(2012) Taku Fujimura et al.   OncoImmunology

Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations

(2012) Elio Schouppe et al.   OncoImmunology

Adrenergic modulation of immune cells: an update

(2011) Franca Marino et al.   AMINO ACIDS

Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma

(2011) Vincenzo De Giorgi et al.   ARCHIVES OF INTERNAL MEDICINE

 -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study

(2011) S. Lemeshow et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients

(2011) Bethany L. Mundy-Bosse et al.   CELLULAR IMMUNOLOGY

Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.

(2011) Steven W. Cole et al.   CLINICAL CANCER RESEARCH

Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth

(2011) Antonio Barbieri et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

(2011) Andrea Facciabene et al.   NATURE

Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E2 through Reduced NK Activity

(2011) Shelly Inbar et al.   PLoS One

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor

(2010) Ariella Glasner et al.   JOURNAL OF IMMUNOLOGY

Macrophages as mediators of tumor immunosurveillance

(2010) Siddhartha Jaiswal et al.   TRENDS IN IMMUNOLOGY

Arginase: an emerging key player in the mammalian immune system

(2009) Markus Munder   BRITISH JOURNAL OF PHARMACOLOGY

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

(2009) Zvi G. Fridlender et al.   CANCER CELL

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression

(2008) Eric V. Yang et al.   BRAIN BEHAVIOR AND IMMUNITY

Relationship between CD107a expression and cytotoxic activity

(2008) Esin Aktas et al.   CELLULAR IMMUNOLOGY